LDS/Medical Tests/Glucose-6-Phosphate Dehydrogenase (G6PD)

Glucose-6-Phosphate Dehydrogenase (G6PD)

Glucose-6-Phosphate Dehydrogenase is an enzyme used in the catalyzation of the hexose monophosphate pathway. Its action is to remove peroxide and prevent the red blood cell from oxidative damage. G6P deficiency is associated with Heinz bodies, poikilocytes, and occasional spherocytes noted on the peripheral smear. G6PD has been considered a housekeeping gene protecting the red blood cells from oxidative damage. A deficiency of G6PD can lead to the destruction of Red Blood Cells through the process of hemolysis when the body is exposed to certain drugs or the stress of infections. When the body cannot compensate for this destruction of RBCs this leads to anemia. There are over 440 different mutations of G6PD isoenzymes. Of these the G6PD-A(+) isoenzymes and G6PD-A(–) are most significant in the African-American population as 10% to 15% carry the variant. Some Mediterranean people have the B– variant that has an extremely low enzyme activity. G6P deficiency is an X-linked recessive disease which means it can be passed on from either parent.

The World Health Organization has sub-classified the 440 plus isoenzymes into four separate classes based on severity of the disease from Severe Enzyme Deficiency to No Enzyme Deficiency.

  • Class I, severe enzyme deficiency associated with chronic hemolytic anemia (<10% of normal enzyme activity)
  • Class II, severe enzyme deficiency with intermediate hemolysis associated with hemolytic anemia
  • Class III characterized with less severe or moderate enzyme deficiency associated with moderate or mild hemolytic anemia
  • Class IV or normal phenotype with no enzyme deficiency and no hemolytic anemia.

Since this is an X-linked disorder, partial expression can be found in female heterozygotes who will show a dual population of red blood cells, one normal and one deficient.

  • Aid in the diagnosis of glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • As an aid in diagnosis of hemolytic anemias
  • Differential diagnosis of red blood cell hemolysis

Increased in:

  • Increased erythrocytes production due to related proliferative disorders (Marked Reticulocytosis)

Note: false normal results may be obtained after hemolytic episodes so testing may need to be repeated if anemia goes undiagnosed and values are normal

Decreased in:

  • G6PD deficiency

Erythrocytes: 0.117-0.143 U/million cells.
 

 

Spectrophotometrically.

Whole Blood EDTA (Lavender) or ACD (Yellow). 

Stability

  • Ambient: 48 hours
  • Refrigerated: 7 days
  • Frozen: Unacceptable
Heinz Body Stain, Hemosiderin Urine, G6PD Screen.
1-4 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Hematology. 2010 Apr;15(2):122-4. [PMID: 20423573]
  • Am Fam Physician 2004;69:2599. [PMID: 15202694]
  • Semin Perinatol. 2004 Oct;28(5):356-64. [PMID: 15686267]
  • Am Fam Physician 2005;72:1277. [PMID: 16225031]
  • Anderson, Shauna C., Cockayne, Susan, (1993) Clinical chemistry: concepts and applications. Philadelphia. W.B. Saunders Company.
  • Jacobs, David S., DeMott, Wayne R., (2001). Laboratory test handbook. 5th. Hudson, OH. Lexi-Comp, Inc.